Federal funds could begin running dry Saturday that help tens of millions of Americans to buy food for their families and ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

Science must guide treatment decisions, and healthcare practitioners must take decisive action now to stop inappropriate fibrate prescribing for cardiovascular risk reduction, especially on top of ...

(THE CONVERSATION) The Supplemental Nutrition Assistance Program, or SNAP, is the largest, most effective tool the U.S. has to reduce food insecurity. As of late 2025, it helps more than 42 million ...

GLP-1 agonists like Ozempic are primarily used to treat type 2 diabetes. Its popularity has even influenced wholesale retailer Costco to sell Ozempic and Wegovy (another popular semaglutide) at its ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

Glucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have gained popularity globally, not just for managing type 2 diabetes but also due to ...

Steven Woloshin is a professor at the Dartmouth Institute for Health Policy and Clinical Practice and founder of the Lisa ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...